SCHEMBL5649656

SCHEMBL5649656

COCCOc1cc(NC=C2C(=O)OC(C)(C)OC2=O)ccc1OC

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 18/20 0.56
HSD17B10 Q99714 4/20 0.56
MAPK1 P28482 1/20 0.56
CASP1 P29466 2/20 0.54
CASP7 P55210 2/20 0.54
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
KMT2A Q03164 2/20 0.47
RAB9A P51151 1/20 0.46
HPGD P15428 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374339 0.88 ALDH1A1 (0.67) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL16619650 0.87 ALDH1A1 (0.52) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL6431219 0.85 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL6433972 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL17675496 0.84 ALDH1A1 (0.48) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL6430655 0.83 ALDH1A1 (0.48) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL6431158 0.82 TSHR (0.47) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL20032548 0.80 ALDH1A1 (0.64) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL25260320 0.80 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL6431438 0.79 ALDH1A1 (0.62) ALDH1A1HSD17B10MAPK1CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 ALDH1A1 530/4885HSD17B10 2150/4885MAPK1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.